The results of the screening of peripheral polyneuropathy in patient with diabetes mellitus type 2 on the work results of diamobile in Novosibirsk region
Author Affiliations1Novosibirsk State Medical University of Minzdrav of Russia 630091, Novosibirsk, Krasny av., 52; Novosibirsk State Regional Clinical Hospital 630087, Novosibirsk, Nemirovicha-Danchenko str., 130
2Novosibirsk State Medical University of Minzdrav of Russia 630091, Novosibirsk, Krasny av., 52
3Novosibirsk State Medical University of Minzdrav of Russia 630091, Novosibirsk, Krasny av., 52
4Novosibirsk State Regional Clinical Hospital 630087, Novosibirsk, Nemirovicha-Danchenko str., 130
Abstract
The results of screening for diabetic peripheral polyneuropathy in patients with diabetes mellitus type 2 received by Diamobile in the Novosibirsk region have been estimated. 874 patients with diabetes mellitus type 2, aged 59,8 ± of 8.7 years have been surveyed. The diabetes duration varied from the first identified to 47 years, the average of 8.1 ± 6.9 years. The diabetic peripheral neuropathy has been revealed in more than half of the patients. Its relationship with parameters of carbohydrate metabolism and duration of diabetes and hypertension has been established.
Key words
References1. Gur’eva I.V. The risk factors for the development of diabetic foot syndrome // Russkiy meditsinskiy zhurnal. (6). 318–321. (in Russian)
2. Dedov I.I. Algorithms of specialized medical treatment of patients with diabetes mellitus. Moscow, 2013. 120 p. (in Russian)
3. Suncov Yu.I. Screening for diabetes complications as a method of assessing the quality of medical care to patients. Moscow, 2008. 80 p. (in Russian)
4. Tirikov I.V. Diabetic neuropathy (frequency, risk factors, forecasting, development variants of the clinical course) abstract of thesis…candidate of medical sciences. Irkutsk, 201. (in Russian)
5. Global health risks. Mortality and burden of disease attributable to selected major risks. Geneva, World Health Organization, 2009.
6. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030 // PLoS Med. 2006. 3. (11). e442.
7. Tavakoli M., Malik R.A. Management of painful diabetic neuropathy // Expert Opin. Pharmacother. 2008. 9. (17). 2969—2978.
8. Tesfaye S., Chaturvedi N., Simon E.M. et al. Vascular risk factors and diabetic neuropathy // New Engl. J. Med. 2005. 4. (352). 341–350.
9. Zochodne D. Diabetic polyneuropathy: an update // Curr. Opin. Neurol. 2008. 21. (5). 527–533.
10. Ziegler D., Rathmann W., Dickhaus T. et al. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3 // Diabetes Care. 2008. 31. 464–469.
About Authors (Correspondence):
Labetskiy Ya.K. – postgraduate student of the chair for neurology, e-mail: 12z@ngs.ru
Doronin B.M. – doctor of medical sciences, professor, chief of the department of neurology
Bondar’ I.A. – doctor of medical sciences, professor, chief of the department of endocrinology
Shabel’nikova O.Yu. – candidate of medical sciences, head of endocrinological department
Full Text
